Tag: cabotegravir

A global three-year study has successfully shown that a long-acting injectable drug dosed every two months can be more effective than the daily PrEP. Worldwide HIV medical specialist company ViiV Healthcare today announced an interim analysis of the HIV Prevention Trials Network that has been evaluating the safety and efficacy...